Does pfizer make viagra?

Pfizer is the manufacturer of Viagra, a drug used for erectile dysfunction. The brand has been a huge success for the company, generating billions in sales annually. Pfizer also released a generic version in 2017.

Pfizer and Viagra

Pfizer, a leading pharmaceutical company, has a significant history with Viagra, a well-known erectile dysfunction drug. The small blue pill has been synonymous with Pfizer since its approval by the Food and Drug Administration (FDA) 20 years ago.

Pfizer's History with Viagra

Pfizer struck chemical gold with the development and FDA approval of Viagra.

The drug has been a groundbreaking product, particularly in the erectile dysfunction market, generating around 500 million U.S. dollars in revenue in 2019 alone.The drug's active ingredient, also sold under the name Sildenafil, is what makes Viagra effective.

Pfizer's Exclusive Rights to Viagra

For nearly two decades, Pfizer maintained exclusive rights to the brand-name erectile dysfunction drug Viagra. During this period, Viagra became a globally recognized product, contributing significantly to Pfizer's revenue. However, steady declines in sales were observed over the past seven years, particularly after patent protection expired outside the U.S. in 2012.

Settlement between Pfizer and Teva Pharmaceuticals

In a strategic move in 2013, Pfizer settled with Teva Pharmaceuticals, allowing the latter to market a generic version of Viagra. This agreement marked the end of Pfizer's exclusive hold on the product, opening up the market to more affordable options for patients.

Introduction of Generic Viagra by Teva Pharmaceuticals

Teva Pharmaceuticals' introduction of generic Viagra offered a less expensive alternative to the brand-name drug. The generic version maintained the efficacy of the original, providing the same benefits at a lower cost.

Pfizer's Decision to Join the Generic Market

With the introduction of generic Viagra by other companies, Pfizer decided to enter the generic conversation. In a move to maintain market relevance and consumer reach, Pfizer announced its intention to produce a generic version of Viagra.

Pfizer's Announcement to Sell Its Generic Version of Viagra

On December 28, 2017, Pfizer officially launched its own generic version of Viagra, known as sildenafil. The generic version was touted to cost approximately half the price of the brand-name pill, making it more affordable for a broader range of consumers.

Comparison of Prices Between Brand-Name and Generic Viagra

Pfizer's sildenafil, the generic version of Viagra, significantly undercut the cost of the brand-name drug. The company's decision to offer a more affordable alternative demonstrated its commitment to accessibility and affordability in healthcare.

In addition, Pfizer's U.S. subsidiary, Greenstone, part of the Upjohn company, reached an exclusive supply deal with telehealth provider Roman for access to Pfizer's FDA-approved product. This move further demonstrated Pfizer's ongoing commitment to ensuring the accessibility of their products.

Pfizer's Role in Producing Viagra

In summary, Pfizer, the original producer of Viagra, continues to play a significant role in its production, both of the brand-name drug and its own generic version. The company's actions demonstrate a commitment to patient accessibility and affordability, with the launch of generic versions and partnerships with telehealth providers.

Points de prudence pour Does pfizer make viagra?

Avant d’agir, il faut replacer la réponse dans le contexte médical personnel: âge, symptômes associés, traitements déjà pris, antécédents cardiovasculaires, diabète, tension artérielle, effets indésirables et objectif réel de la recherche. Une information générale peut aider à préparer une discussion, mais elle ne permet pas de choisir seul une dose, de remplacer un médicament ou d’ignorer une contre-indication.

La démarche la plus sûre consiste à noter la fréquence du problème, les circonstances où il apparaît, les médicaments ou compléments utilisés et les signes qui nécessitent une consultation rapide. Cette mise au point aide à distinguer une question ponctuelle d’un trouble persistant, à éviter les achats non contrôlés et à comprendre pourquoi certaines options exigent une prescription ou une surveillance.

Ces informations servent donc d’orientation générale. Elles ne remplacent pas une consultation, un diagnostic ou une prescription adaptés à la situation individuelle.